Search Options
close
Search the following clips:
All Clips
Everyone's Clips
My Guides
Sign Up
Install
Learn More
Login
Epix Soars 50% On Alzheimer's Data
BobbyDelray
follow
1
12-19-2007 10:34 PM
247 views
tags:
alzheimer's
,
epix
,
alzheimer’s disease assessment scale
,
brain
1 Comment
|
Add a Comment
12-29-2007
6:17 AM
tayoulevy
let us hope it is true. let it be a breakthough for 2008
Login
to Comment. Not a member yet?
Sign up
Related Clips
Drug for Longer Life
MUST READ: Taco Bell makes special deliver...
How smart are 'smart drugs'?
Physical fitness may slow Alzheimer brain ...
Scientists find why we need to re-read a page
Exercise Not Proved to Help Dementia
Dementia & Alzheimer's Prevention Starts Now
More clips from
BobbyDelray
'World's greatest dad' charged in online c...
Was Jimmy Carter an energy prophet?
Cops stop 8K from 'mooning' trains in Cali...
Today's Top Clips
High Speed Photography
Hero
Do Not Read This !
Jupiter
'Last Lecture' professor dies at 47
California becomes first state to ban trans fats
My Doggies
Time as an abstract idea –beautiful illustration
How Many Silicon Valley Startup Executives Are Hopped Up On Provigil?
Extinguishing the Fear at the Roots of Anxiety
visit the
Top Clips page
View the Top Clips from
December 19, 2007
Embed This Clip In Your Site...
<div style="margin: 12px 0px; font-family: arial; color: #333333; background: #ffffff; border: solid 4px #e5e5e5; width: 100%; clear: left;"><div class="CM_CTB_Content_Wrap" style="margin: 0px; padding: 0px;background-color: #ffffff;"><div style="border-bottom: solid 1px #dcdcdc; white-space: nowrap; margin-bottom: 8px; background-color: #eeeeee ;background-image: url(http://www.clipmarks.com/images/source-bg.gif); background-repeat: repeat-x; height: 24px; line-height: 24px; vertical-align: middle; padding-bottom: 4px; color: #666666; font-size: 10px;" ><a href="http://clipmarks.com/clip-to-blog/" title="see clips that are hot right now"><img src="http://content.clipmarks.com/blog_embed/74a7f235-0e5b-4e71-9801-874ded3a929b/B41666E5-08A2-4135-880A-FE6A695DF336/" alt="" width="19" height="19" border="0" style="vertical-align: middle; margin: 0px 4px; display: inline; border: none; float:none;" /></a>clipped from <a title="http://blogs.forbes.com/sciencebizblog/2007/12/epix-soars-50-o.html" href="http://blogs.forbes.com/sciencebizblog/2007/12/epix-soars-50-o.html" style="font-size: 11px;">blogs.forbes.com</a></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://blogs.forbes.com/sciencebizblog/2007/12/epix-soars-50-o.html"><BLOCKQUOTE cite="http://biz.yahoo.com/bw/071218/20071218005206.html?.v=1">EPIX Pharmaceuticals (NASDAQ: <A href="http://finance.yahoo.com/q?s=epix&d=t">EPIX</A> - <A href="http://finance.yahoo.com/q/h?s=epix">News</A>), today announced compelling top-line results from a Phase 2a two-week clinical trial of its novel 5-HT4 agonist, PRX-03140, in patients with Alzheimer<SPAN id="bwanpa3">’</SPAN>s disease. The results show that patients receiving 150 mg of PRX-03140 orally once daily as monotherapy achieved a mean 5.7 point improvement on the Alzheimer<SPAN id="bwanpa4">’</SPAN>s Disease Assessment Scale cognitive subscale (ADAS-cog) versus a 0.2 point worsening in patients on placebo (p= 0.005). Patients on a 50 mg dose of PRX-03140 showed a 1.1 point improvement on the ADAS-cog. </BLOCKQUOTE></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://blogs.forbes.com/sciencebizblog/2007/12/epix-soars-50-o.html"><BLOCKQUOTE cite="http://biz.yahoo.com/bw/071218/20071218005206.html?.v=1">After reviewing these data, Serge Gauthier, M.D., Director of the Alzheimer's Disease Research Unit at McGill University, stated, <SPAN id="bwanpa11">“</SPAN>There is such an urgent and undeniable need for additional safe and effective treatments for Alzheimer<SPAN id="bwanpa12">’</SPAN>s patients. Findings like these data are not only encouraging and compelling <SPAN id="bwanpa13">–</SPAN> they appear to represent a step forward in our ability to understand and combat the effects of Alzheimer<SPAN id="bwanpa14">’</SPAN>s.</BLOCKQUOTE></blockquote></div><div style="margin: 0px 6px 6px 4px;"><table style="font-size: 11px;border-spacing: 0px;padding: 0px;" cellpadding="0" cellspacing="0" width="100%"><tr><td style="background:transparent;border-width:0px;padding:0px;"> </td><td align="right" style="background:transparent;border-width:0px;padding:0px;width:107px" width="107"><a href="http://clipmarks.com/share/B41666E5-08A2-4135-880A-FE6A695DF336/blog/" title="blog or email this clip"><img src="http://content6.clipmarks.com/images/c2b-foot.png" border="0" alt="blog it" width="107" height="17" style="border-width:0px;padding:0px;margin:0px;" /></a></td></tr></table></div></div>
Clipmarks
Home
New Clips
Top Clips
Dashboard
Popular Topics
News
Life
Science
Technology
Entertainment
Get Started
Sign Up
Install Clipping Tool
How Clipping Works
Clip-to-Blog™
ClipSearch
Tools and Resources
FAQ
ClipWeek
Top Clippers
Top Tags
Site Map
About Clipmarks
About Us
Contact
Blog
Copyright
Privacy
EULA
OK